Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Observational Study Investigating the Safety and Effectiveness of Fluciclovine (18F) (FACBC) PET Ligand in Human Subjects

NCT02443571 is registered in ClinicalTrials.gov with Blue Earth Diagnostics as lead sponsor.

NCT NCT02443571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02443571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Observational Study Investigating the Safety and Effectiveness of Fluciclovine (18F) (FACBC) PET Ligand in Human Subjects
Lead sponsor
Blue Earth Diagnostics
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
June 30, 2015
Enrollment
714 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms